Veraxa Biotech AG (VRXA)
Nasdaq: VRXA · Pharmaceutical Preparations · filing with the SEC since 2025
Who runs Veraxa Biotech AG
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Antz Christoph Rudiger
Chief Executive Officer. First filing Jun 2026, latest Aug 31, 2026, 1 filing in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
9 people on the record since 2026
Officerssales are open-market, Oct 29, 2025 to Oct 29, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Willener Raju Sudir | Chief Financial Officer | Sep 2026 | Sep 14, 2026 | none |
| Antz Christoph Rudiger | Chief Executive Officer | Jun 2026 | Aug 31, 2026 | none |
| Von Halem Carl | Interim CFO | Aug 2026 | Aug 20, 2026 | none |
| Buergermeister Torsten Georg Friedrich | Chief Financial Officer | Jun 2026 | Jun 9, 2026 | none |
| Schwer Heinz | Chief Business Officer | Jun 2026 | Jun 9, 2026 | none |
Directorssales are open-market, Oct 29, 2025 to Oct 29, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gruninger Marc | director | Jun 2026 | Oct 29, 2026 | none |
| Ziegler Christoph Samuel | director | Jun 2026 | Oct 21, 2026 | none |
| Baumann Oliver Rolf | director | Jun 2026 | Aug 31, 2026 | none |
| Hosseinion Warren | director | Jun 2026 | Jun 9, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.